A selective system was developed that permits the isolation of heterokaryons and cell hybrids between any cell types without the use of selectable genetic m.arkers. Antibodies were introduced into two populations of non-transformed normal diploid human fibroblasts by the osmotic lysis of pinosomes containing hypertonic antibody solutions. Heterokaryons formed by'fusing antiricin-injected cells to antidiphtheria toxin-injected cells survived an overnight treatment in both ricin and diphtheria toxin. This approach should have general applicability to a variety of investigations such as the complementation analysis of human genetic syndromes, heterokaryon studies of cell differentiation, tumorigenesis and growth control, cell reconstruction experiments, and the production of hybridoma cells.
hybridization is used to probe the mechanisms regulating cell differentiation or to analyze complementation groups in human genetic syndromes. In general, differentiated functions are suppressed in cell hybrids involving combinations of cells from different developmental lineages, and it has been difficult to pursue this negative result. Furthermore, the existence of gene dosage effects (1-3) and chromosome segregation (3) (4) (5) combine to make almost any result possible, and thus the literature is filled with confusing and contradictory data. The major difficulty in applying somatic cell fusion to the complementation analysis of human genetic syndromes is that most selective systems for isolating fusion products require the introduction of selectable genetic mutations [e.g., thymidine kinase and hypoxanthine guanine phosphoribosyl transferase mutations in the hypoxanthine/aminopterin/thymidine (HAT) system (6) ]. The limited proliferative capacity of normal diploid cells (7) effectively prevents these manipulations.
In order to circumvent these and other difficulties a method was developed previously for isolating heterokaryons and cell hybrids based on the complementation of the lesions introduced by two different irreversible biochemical inhibitors (8) (9) (10) . Although successful, this approach was technically demanding and inevitably raised questions as to the alterations in phenotype potentially introduced by the drastic treatments to which the cells were exposed. Other groups have reported only limited success using the fluorescenceactivated cell sorter (11) or velocity sedimentation (12, 13) to enrich for cell fusion products.
An alternative method for isolating heterokaryons was made possible by the elegant technique for introducing macromolecules into cells described by Okada and Rechsteiner (14) . Cells are exposed to a hypertonic solution containing the macromolecule and allowed to pinocytize for 10 min.
The cells are then briefly hypotonically shocked before these newly formed pinosomes have a chance to reach the lysosomes. Because the pinosomes are small they have little volume expansion capacity relative to the entire cell and thus swell and burst, releasing their macromolecular contents into the cytoplasm. I here report that if antiricin antibodies are introduced into one population of cells and antidiphtheria toxin antibodies are introduced into a second, highly enriched populations of heterokaryons can be isolated if the two cell types are fused and plated in the presence of both toxins. Only heterofusion products contain both antibodies and are thus'protected from both toxins and survive. The technique is simple and straightforward to use, works by the prevention of cell damage rather than the complementation of cellular lesions, isolates highly enriched populations of heterokaryons and cell hybrids with high efficiency, and represents a substantial improvement over previous methodologies.
MATERIALS AND METHODS
The normal human diploid cell strain HEL 229 (ATCC CCL137, human embryonic lung fibroblasts) was obtained from the American Type Culture Collection (Rockville, MD), and the xeroderma pigmentosum cells GM2991 (complementation group A) and GM2992 (complementation group C) were obtained from the Human Genetic Mutant Cell Repository (Camden, NJ) and cultured using standard techniques.
Antiricin monoclonal antibodies were produced by immunizing mice with formaldehyde-treated ricin toxoid (15) . Hybridoma clones were initially screened for the ability of culture supernatant (50 Al, diluted to a final volume of 150,41) to prevent the lethal effects of 3 ng of'ricin per ml on human fibroblasts. Antibodies to both the ricin B chain (responsible for binding and uptake) and the ricin A chain (the catalytic subunit) gave positive results in this initial screening. Monoclonal antibodies with blocking activity against the catalytic ricin A chain were then identified by the ability of osmotically injected antibody (20- fold concentrated culture supernatant) to protect against the lethal effects of ricin. Positive hybridomas were'then cloned and retested. The clone R6f provided the greatest degree of protection and was used for the production of ascites. Antidiphtheria toxin polyclonal antibodies were produced by immunizing rabbits with diphtheria toxoid (Connaught Laboratories, Willowdale, ON, Canada). The polyclonal antibodies were concentrated 15-fold following their precipitation in 50% ammonium sulfate, dialysis against 6 mM sodium phosphate buffer (pH'7.2), sterile filtration, and lyophilization. The antidiphtheria toxin antibodies were then dissolved in hypertonic sucrose/polyethylene glycol (PEG) solution (0.5 M sucrose and 10% PEG 1000 in serum-free medium).
Antibodies were injected into the cells by using the technique for cells in suspension developed by Okada and Rechsteiner (14) . Cultures were trypsinized, counted, and centrifuged for 2 min at 700 x g. The supernatant was removed by Abbreviation: PEG, polyethylene glycol.
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The publication costs of this article were defrayed in part by page charge payment. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. §1734 solely to indicate this fact. first decanting the liquid, briefly recentrifuging in order to drive liquid adhering to the walls of the tubes down to the bottom, and then carefully aspirating the remaining fluid. The cell pellet was vigorously resuspended in hypertonic sucrose/PEG containing the desired antibody using 0.4 ml per 107 human fibroblasts. Volumes of hypertonic antibody of <0.2 ml per 107 fibroblasts resulted in a reduced efficiency of antibody injection. The cells were incubated in a 370C water bath for 10 min with occasional agitation to maintain the cells in suspension. The hypertonic solution (0.1-0.4 ml) was diluted by the addition of 10 ml of warm 60% serum-free medium (medium/distilled water, 6:4) to hypotonically shock the cells and cause the newly formed pinosomes to burst.
Two minutes later the cells were centrifuged and resuspended in isotonic medium. Varying the parameters from those originally described (changing the sucrose concentration, time in hypertonic medium, or time in hypotonic medium) did not result in increased amounts of protection against the appropriate toxin. Although increasing the time in hypertonic solution resulted in a significant decrease in viability, the cells tolerated increased hypotonic exposure quite well. No significant change in viability was observed over a 2-to 15-min hypotonic treatment (including the time for centrifugation, this represents an 8-to 21-min total exposure to hypotonic conditions). Two 10-ml washes (including the resuspension of the cell pellet from the hypotonic treatment) were sufficient to remove free antibody if the pellet was carefully aspirated to dryness during each wash cycle.
The degree of protection conferred by the antibodies was assessed by comparing the survival of antibody-injected versus control cells in serial 1:3 dilutions of the toxin. Cells were plated at 25-50 x 103 cells per cm2 in toxin-containing medium on day 0, incubated overnight, and then fed toxinfree medium on day 1. It was not necessary to wash the cells to remove all traces of toxin, since identical results were obtained if-the toxin-containing medium was simply aspirated and replaced with fresh medium. Cells treated with lethal doses of toxin generally looked reasonably healthy on day 1, appeared to be sick on day 2, and had died and detached from the dish by day 3. Viability was functionally defined for fibroblasts as being attached and well spread 3 days after toxin treatment. Experiments were analyzed 3 days after the start of the experiment by visually comparing the survival at each toxin concentration to that in toxin-free controls. The degree of protection was calculated by dividing the LD50 of antibody-injected cells by the LD50 obtained using control cells.
In a typical experiment, 5 x 106 cells of each type were treated with 0.2 ml of either hypertonic R6f antiricin ascites or antidiphtheria toxin serum, hypotonically shocked, and centrifuged. The cell pellets were resuspended in 10 ml of medium and one-third was removed to determine the degree of toxin protection produced. These cells would later be centrifuged, washed, and plated in serial 1:3 dilutions of toxin. The remaining cells were mixed together and repelleted. The supernatant was decanted, and the tube was briefly recentrifuged to remove liquid adhering to the walls. The pellet was aspirated to dryness and then vigorously resuspended for 15 sec in 0.2 ml of 35% (vol/vol) PEG 1000/10% (vol/vol) dimethyl sulfoxide in serum-free medium. The fusing cells were gently agitated by rolling the centrifuge tube for 45 sec, and the reaction was terminated by the addition of 10 ml of complete medium containing 10% fetal bovine serum. Under these conditions, newly fused cells become resistant to vigorous trituration within 15-20 min at room temperature. The cells were thus left at room temperature for 30 min, centrifuged, resuspended, and plated overnight in medium containing both ricin and diphtheria toxin at the desired concentrations. Approximately 20 hr later the cells were fed toxinfree medium. The cells were fixed in 95% ethanol 3 days after fusion, Giemsa stained, and counted to determine the purity (% of total nuclei present in cells containing more than one nucleus) and efficiency of rescue (% of nuclei in toxinfree aliquots recovered as viable heterokaryons in toxintreated aliquots). The best results were obtained when dividing rather than confluent cultures of human fibroblasts were used.
Under these conditions, -80% of the cells are actually recovered following each centrifugation. Following four centrifugations the final number of cells is thus reduced to 40o of the initial value. The plating densities described refer to the actual plating densities, not those determined by initial cell counts. Fig. 1 A and B show the degree of protection of normal diploid human embryonic lung fibroblasts (HEL 229 cells) conferred by osmotically injecting either monoclonal antiricin R6f mouse ascites fluid or polyclonal antidiphtheria toxin rabbit serum. In this experiment the antiricin antibody provided a 140-fold protection against the effects of ricin, whereas the antidiphtheria toxin antibody provided a 50-fold protection against diphtheria toxin. Antiricin-injected cells showed no cross-protection against diphtheria toxin and vice versa.
RESULTS
The cells from the same experiment as Fig. 1 were mixed, fused, and plated in a matrix of ricin and diphtheria toxin concentrations in order to determine the purity and efficiency of cell rescue as a function of toxin dose. Fig. 2A shows that at 3 ng of diphtheria toxin per ml, populations in which >90% of the nuclei were in cells with more than one nucleus were obtained with all ricin concentrations above -1 ng/ml. Fig. 2A also shows that R6f antiricin antibody confers excess protection on the cells, since the efficiency of rescue does not decline significantly with increasing ricin concentrations. In contrast, Fig. 2B shows that the polyclonal antidiphtheria toxin serum is providing adequate but not excess protection. Although sufficiently active to produce complete rescue of heterokaryons at concentrations that kill control cells, the efficiency of rescue declines precipitously at higher diphtheria toxin concentrations.
Aliquots of control cells fixed 16 hr after cell fusion showed that 30% of the nuclei were present in cells with more than one nucleus compared to a 2-3% background in unfused cultures. If all fused cells were binucleated and half were homokaryons and half heterokaryons, then an efficien- Protection by osmotically injected antibodies against killing by toxins. Normal diploid human fibroblasts (HEL 229) were exposed to hypertonic solutions containing polyclonal antidiphtheria toxin serum (A) or monoclonal antiricin R6f ascites fluid (B) and then were hypotonically shocked. The degree of protection conferred by the antibody was determined from the cell survival 3 days later following an overnight exposure to increasing toxin concentrations. e, Control cells; o, antibody-injected cells. Antiricin-injected cells conferred no protection against diphtheria toxin and vice versa (data not shown). Plating cells at increasing densities showed that the purity of the rescued heterokaryons declines at plating densities of >50-100 x 103 cells per cm2 (Fig. 3) . The effect is primarily due to cell density (cells per cm2) rather than limiting amounts of toxin (cells per ml), since a constant number of cells per milliliter plated in decreasing surface areas also showed the effect. Although the density of surviving heterokaryons from populations plated at 25-50 x 103 cells per cm2 is adequate for many purposes, higher densities can be obtained by initially plating the cells at low densities, then trypsinizing the culture 2 days after cell fusion, and replating the cells at whatever density is desired. The functional viability of the rescued heterokaryons is demonstrated by the fact that >50% of the heterokaryons are able to reattach and spread following this procedure.
The functional viability of toxin-antitoxin-purified heterokaryons is also demonstrated by the ability of cells from different xeroderma pigmentosum complementation groups to complement their defects in these heterokaryons. Table 1 shows the efficiency of UV-induced DNA repair in parental and fused cells under both unselected and purified conditions. Under unselected conditions the degree of UV repair of parental cells fused to themselves (unselected homokaryons) was compared to that in cells mixed after self-fusion ("mixed": mixture of unselected homokaryons) or in cells mixed and then fused ("fused": unselected heterokaryons). Under selected conditions, toxin-antitoxin selection was used to isolate >90% pure populations of either self-self homokaryons or complementation group A-group C heterokaryons. The DNA repair activity in the unselected heterokaryons is only marginally greater than in the GM2992 parental cells. However, comparing the level of activity of unselected mixed homokaryons versus fused heterokaryons demonstrates that complementation has occurred. Although in this case complementation can be demonstrated in the unselected populations, the increased sensitivity of detection in the purified population of heterokaryons is dramatic. The toxin-antitoxin-isolated heterokaryons exhibit a nearly normal level of DNA repair that is almost an order of magnitude greater than that seen in the GM2992 homokaryons.
The suitability of the toxin-antitoxin selective system for other procedures in somatic cell genetics was examined in two other applications. Fig. 4 shows the ability of antiricininjected enucleated rat myoblasts to rescue whole cells. The increased survival in cytoplast-whole cell fusions versus mixture controls indicates that the technique is effective for the selection of cybrids. Preliminary experiments ( more than an order of magnitude more efficient than the HAT system for the production of hybridoma colonies. The relative number of colonies in mixed versus fused aliquots suggests that about 95% of the fused colonies should be hybridomas. Since a non-immunized animal was used in this demonstration experiment, the proportion of colonies secreting antigen-specific antibodies could not be determined. DISCUSSION
The ability to easily isolate heterokaryons and cell hybrids with high efficiency using essentially any cell types should have wide applications to many problems in research, clinical medicine, and the biotechnology industry. Although the approach will be useful in terms of the simple convenience of not having to introduce selectable genetic markers into the cell lines of interest, its primary importance lies in more qualitative advantages over current techniques. Some areas in which this technique should provide significant changes in experimental strategy include the complementation analysis of genetic disorders, studies of the mechanisms regulating cell differentiation, and the isolation of hybridomas. The complementation analysis of human genetic syndromes has been severely hampered by the inability to separate the fusion products from unfused parental cells. Since non-transformed normal diploid cells can be used in the toxin-antitoxin selection system, it should now be possible to study the entire repertoire of human and animal mutations by using cell fusion techniques. Furthermore, since large numbers of heterokaryons can be isolated, many of the experiments could be performed on mass populations of heterokaryons within a few days of their production without the need to wait until hybrid colonies develop. (21) . After recovering in cytochalasin-free medium at 370C for 30 min, the anucleate cytoplasts were trypsinized, pelleted, and injected with antiricin antibodies. Half of the cytoplasts were then mixed with L6 myoblasts and fused ("Fused"). The remaining half of the cytoplasts were fused to themselves with PEG and then mixed with L6 myoblasts that had been fused to themselves ("Mixed"). The cells were plated overnight in increasing concentrations of ricin, fed toxin-free medium, and fixed and Giemsa stained 4 days later. The limited survival at 3 and 30 ng of ricin per ml in the mixture controls is due to the survival of the 5% of L6 myoblasts that failed to enucleate. The increased survival in the experimental fusions indicates that heteroplasmons were rescued and that anucleate cytoplasts can take up sufficient amounts of antiricin antibodies to confer protection to at least a 10-fold range of otherwise lethal ricin concentrations.
The toxin-antitoxin selection technique isolates the initial fusion product, the heterokaryon. Although the heterokaryons can then be cultured in order to give rise to hybrid colonies, the abilty to isolate heterokaryons rather than just cell hybrids is another powerful advantage of toxin-antitoxin selection over techniques such as HAT selection. The theoretical rationale for why heterokaryons might have a very differ- (29, 30) or fluorescent activated cell sorting (31) result in the recovery of only a small fraction of the initial population of spleen cells, if they succeed in enriching for the fraction that is antigen specific then the use of toxin-antitoxin selection would still yield adequate numbers of colonies for study. Alternatively, toxin-antitoxin-selected hybridomas could be grown as mass populations (rather than colonies) for the first week following cell fusion, and then hybridoma cells bearing specific antibodies on their surface could be isolated by panning and cloned. Even if the fraction of memory B cells in peripheral blood is very low, enrichment techniques coupled to the increased colony yield provided by toxin-antitoxin selection should make peripheral blood a viable source of cells for hybridoma production. This would have a profound influence on the use of human cells for the production of monoclonal antibodies. The technique also makes it possible to use cells immortalized using one approach in subsequent rounds of cell hybridization. For example, EB virus transformed human lymphocytes secreting low levels of antibody could be fused to myeloma cells in order to increase antibody production. Hybridoma cells selected for particular characteristics could also be used in a second round of hybridization without having to reintroduce a selectable marker.
Since mouse and rat cells are resistant to diphtheria toxin (32), antidiphtheria toxin antibodies are not useful for selecting heterokaryons or hybrids involving these cells. However, antiricin, antiabrin, antimodeccin, or other antitoxin antibodies should provide the flexibility necessary for using toxin-antitoxin selection for isolating mouse or rat cell hybrids. The ability of toxin-antitoxin selection to easily isolate somatic cell heterokaryons and hybrids between any cell types provides a variety of qualitative and quantitative advantages over current approaches and should prove valuable in extending the range of questions that can be investigated by using somatic cell genetics.
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